Cargando…

Post hoc analyses of response rates to pharmacological treatments in children and adolescents with attention-deficit/hyperactivity disorder

INTRODUCTION AND OBJECTIVES: Lack of consensus regarding how best to define treatment response hinders translation from trials to the clinic. These post hoc analyses examine three commonly used response criteria in six trials of lisdexamfetamine dimesylate (LDX) in children and adolescents with atte...

Descripción completa

Detalles Bibliográficos
Autores principales:	Coghill, David R, Newcorn, Jeffrey H, Chen, Jie, Werner-Kiechle, Tamara, Banaschewski, Tobias
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Original Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7376623/ https://www.ncbi.nlm.nih.gov/pubmed/32043417 http://dx.doi.org/10.1177/0269881120904949

Ejemplares similares

Post hoc analyses of the impact of previous medication on the efficacy of lisdexamfetamine dimesylate in the treatment of attention-deficit/hyperactivity disorder in a randomized, controlled trial
por: Coghill, David R, et al.
Publicado: (2014)

Molecular genetics of attention-deficit/hyperactivity disorder: an overview
por: Banaschewski, Tobias, et al.
Publicado: (2010)

A Post Hoc Comparison of the Effects of Lisdexamfetamine Dimesylate and Osmotic-Release Oral System Methylphenidate on Symptoms of Attention-Deficit Hyperactivity Disorder in Children and Adolescents
por: Soutullo, César, et al.
Publicado: (2013)

Cognitive Function of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder in a 2-Year Open-Label Study of Lisdexamfetamine Dimesylate
por: Coghill, David R., et al.
Publicado: (2018)

Functional impairment outcomes in clinical trials of different ADHD medications: post hoc responder analyses and baseline subgroup analyses
por: Coghill, David R., et al.
Publicado: (2020)

Growth and Puberty in a 2-Year Open-Label Study of Lisdexamfetamine Dimesylate in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder
por: Banaschewski, Tobias, et al.
Publicado: (2018)

Long-acting methylphenidate formulations in the treatment of attention-deficit/hyperactivity disorder: a systematic review of head-to-head studies
por: Coghill, David, et al.
Publicado: (2013)

Systematic review of quality of life and functional outcomes in randomized placebo-controlled studies of medications for attention-deficit/hyperactivity disorder
por: Coghill, David R., et al.
Publicado: (2017)

Erratum to: Long-acting methylphenidate formulations in the treatment of attention-deficit/hyperactivity disorder: a systematic review of head-to-head studies
por: Coghill, David, et al.
Publicado: (2015)

Color naming deficits and attention-deficit/hyperactivity disorder: A retinal dopaminergic hypothesis
por: Tannock, Rosemary, et al.
Publicado: (2006)

Weight and Height in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Longitudinal Database Study Assessing the Impact of Guanfacine, Stimulants, and No Pharmacotherapy
por: Schneider, Gary, et al.
Publicado: (2019)

Neurophysiological Correlates of Attentional Fluctuation in Attention-Deficit/Hyperactivity Disorder
por: Cheung, Celeste H. M., et al.
Publicado: (2017)

Guanfacine extended release for children and adolescents with attention-deficit/hyperactivity disorder: efficacy following prior methylphenidate treatment
por: Huss, Michael, et al.
Publicado: (2016)

Gender Effects in the Efficacy of Racemic Amphetamine Sulfate in Children with Attention-Deficit/Hyperactivity Disorder
por: Childress, Ann C., et al.
Publicado: (2019)

Efficacy of lisdexamfetamine dimesylate throughout the day in children and adolescents with attention-deficit/hyperactivity disorder: results from a randomized, controlled trial
por: Coghill, David R., et al.
Publicado: (2013)

Health-Related Quality of Life and Functional Outcomes from a Randomized, Controlled Study of Lisdexamfetamine Dimesylate in Children and Adolescents with Attention Deficit Hyperactivity Disorder
por: Banaschewski, Tobias, et al.
Publicado: (2013)

Comparative efficacy and tolerability of pharmacological interventions for attention-deficit/hyperactivity disorder in children, adolescents and adults: protocol for a systematic review and network meta-analysis
por: Cortese, Samuele, et al.
Publicado: (2017)

The quality of life of children with attention deficit/hyperactivity disorder: a systematic review
por: Danckaerts, Marina, et al.
Publicado: (2009)

Association Between Pharmacological Treatment of Attention-Deficit/Hyperactivity Disorder and Long-term Unemployment Among Working-Age Individuals in Sweden
por: Li, Lin, et al.
Publicado: (2022)

Health-Related Quality of Life and Functional Outcomes from a Randomized-Withdrawal Study of Long-Term Lisdexamfetamine Dimesylate Treatment in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder
por: Banaschewski, Tobias, et al.
Publicado: (2014)

Emotional bias of cognitive control in adults with childhood attention-deficit/hyperactivity disorder
por: Schulz, Kurt P., et al.
Publicado: (2014)

Randomized, Double-Blind, Placebo-Controlled Acute Comparator Trials of Lisdexamfetamine and Extended-Release Methylphenidate in Adolescents With Attention-Deficit/Hyperactivity Disorder
por: Newcorn, Jeffrey H., et al.
Publicado: (2017)

Pharmacological Treatment of Attention Deficit Hyperactivity Disorder in Children and Adolescents: Clinical Strategies
por: Shier, Anna C., et al.
Publicado: (2012)

A Single-Dose, Single-Period Pharmacokinetic Assessment of an Extended-Release Orally Disintegrating Tablet of Methylphenidate in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder
por: Childress, Ann, et al.
Publicado: (2016)

The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: A systematic review with network meta-analyses of randomised trials
por: Catalá-López, Ferrán, et al.
Publicado: (2017)

Non-pharmacologic management of attention-deficit/hyperactivity disorder in children and adolescents: a review
por: Shrestha, Mahesh, et al.
Publicado: (2020)

Twin and Sibling Studies Using Health Insurance Data: The Example of Attention Deficit/Hyperactivity Disorder (ADHD)
por: Langner, Ingo, et al.
Publicado: (2013)

Caregiver perspective on pediatric attention-deficit/hyperactivity disorder: medication satisfaction and symptom control
por: Fridman, Moshe, et al.
Publicado: (2017)

Amfetamine and methylphenidate medications for attention-deficit/hyperactivity disorder: complementary treatment options
por: Hodgkins, Paul, et al.
Publicado: (2012)

The Risk of Hospitalizations with Injury Diagnoses in a Matched Cohort of Children and Adolescents with and without Attention Deficit/Hyperactivity Disorder in Germany: A Database Study
por: Lindemann, Christina, et al.
Publicado: (2017)

Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis
por: Cortese, Samuele, et al.
Publicado: (2018)

Attention-Deficit/Hyperactivity Disorder Remission Is Linked to Better Neurophysiological Error Detection and Attention-Vigilance Processes
por: Michelini, Giorgia, et al.
Publicado: (2016)

Association of Preterm Birth With Attention-Deficit/Hyperactivity Disorder–Like and Wider-Ranging Neurophysiological Impairments of Attention and Inhibition
por: Rommel, Anna-Sophie, et al.
Publicado: (2017)

Attention-deficit/hyperactivity disorder and occupational outcomes: The role of educational attainment, comorbid developmental disorders, and intellectual disability
por: Jangmo, Andreas, et al.
Publicado: (2021)

Supplementation with polyunsaturated fatty acids (PUFAs) in the management of attention deficit hyperactivity disorder (ADHD)
por: Banaschewski, Tobias, et al.
Publicado: (2018)

Genome‐wide analyses of aggressiveness in attention‐deficit hyperactivity disorder
por: Brevik, Erlend J., et al.
Publicado: (2016)

Exome chip analyses in adult attention deficit hyperactivity disorder
por: Zayats, T, et al.
Publicado: (2016)

Attention-Deficit/Hyperactivity Disorder Mimics the Post-concussion Syndrome in Adolescents
por: Cook, Nathan E., et al.
Publicado: (2020)

A post hoc analysis of the effect of viloxazine extended-release capsules on learning and school problems in children and adolescents with attention-deficit/hyperactivity disorder
por: Faraone, Stephen V., et al.
Publicado: (2021)

Sleep Disturbances in Adolescents with Attention-Deficit/Hyperactivity Disorder
por: Gruber, Reut, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_n4m2nk63l0b6brb828jk7i8g5h